UNIPHARMA ApS: Financial statements 2023
CVR: 78881917
UNIPHARMA ApS (CVR 78881917) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -88 the year before. Equity amounted to DKK -124,033.
- Gross Profit
- 0 kr.
- Profit/Loss
- 0 kr.
- Equity
- -124,033 kr.
- Total Assets
- 0 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 0 | 0 | -124 t. | 0 |
| 2022 | 0 | 0 | -88 | 56 t. | - |
| 2021 | - | - | -5 t. | 57 t. | - |
| 2020 | -5 t. | -5 t. | -5 t. | 62 t. | - |
| 2019 | -5 t. | -5 t. | -5 t. | 67 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
UNIPHARMA ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -88.
As of May 1, 2023, Ole Reumert is registered as director of UNIPHARMA ApS.
About UNIPHARMA ApS
UNIPHARMA ApS was a Danish company of the type Anpartsselskab based in København K, founded in 1985. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company is owned by Ebba Dorrit Reumert and Ebba Dorrit Reumert. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK -124,033.
